(Q36671420)

15 August 2017

Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin (English)

1 reference

15 August 2017

1 reference

Gonzalez MA

1

1 reference

15 August 2017

Biswas S

series ordinal

2

1 reference

15 August 2017

Clifton L

series ordinal

3

1 reference

15 August 2017

Corrie PG

series ordinal

4

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

89

1 reference

15 August 2017

3

1 reference

15 August 2017

455-456

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6601167

15 August 2017

0 references

cites work

Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394387

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors

30 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2394387

Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell Carcinoma

20 September 2018

1 reference

12 December 2020

High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer

1 reference

12 December 2020

Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma

1 reference

12 December 2020

Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study

1 reference

12 December 2020

Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell Carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601167

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

PubMed publication ID

12888810

1 reference